Private Equity 24 Hours

Last updated: May 22, 2026, 11:30 PM ET

Deal Activity & Funding Trends Large‑scale capital raises continued to dominate the private‑equity landscape, with the week’s roundup highlighting nine deals exceeding $200 million across aerospace, fintech and retail tech, while AI‑focused investments remained a sizeable share of the pipeline. At the same time, venture‑backed AI startups have been inflating annual recurring revenue figures to secure higher valuations, a practice that investors appear to tolerate as they chase rapid growth in the sector. The juxtaposition of genuine multi‑hundred‑million rounds and stretched revenue metrics underscores a market in which capital is abundant but due‑diligence standards are being tested.

Med Tech Consolidation & Pain‑Management Focus Private‑equity firms are converging on the pain‑management niche, with Charterhouse Capital, Iron Path and Revelar Capital each announcing platform‑level investments and add‑on acquisitions aimed at building integrated care networks. This wave of activity dovetails with the recent merger of two orthopedic manufacturers into a single, Charlesbank‑backed platform, signalling a broader strategy to consolidate fragmented medical‑device segments under unified ownership structures. The combined effect is a sharpening of PE exposure to high‑margin, procedure‑driven healthcare services that benefit from demographic aging and rising chronic‑pain prevalence.

Secondary Market Transactions Frontenac is preparing to divest its controlling interest in the industrials asset MCE, with Churchill Asset Management and 50 South Capital co‑leading the secondary purchase to extend Frontenac’s hold on the portfolio. This move reflects a growing appetite among secondary investors to acquire mature, cash‑generating assets amid volatile primary fundraising conditions. By recycling capital through such transactions, firms can redeploy proceeds into newer, higher‑growth opportunities while preserving exposure to stable industrial cash flows.

Strategic Shifts Toward Yield‑Focused Strategies Partners Group’s Todd Miller outlined a new total‑return strategy that targets mature heavy‑industry and traditional sectors, positioning the firm to capture steady yields in an environment where high‑growth tech funds face valuation compression. Complementing this shift, CVC and GBL launched a take‑private bid for Recordati, a move that illustrates private equity’s willingness to step into the pharmaceutical space when public‑market pricing appears undervalued. Together, these initiatives signal a broader re‑orientation toward sectors that promise predictable cash generation and defensive resilience.